About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

A Phase I Clinical Trial to Evaluate Immune Response Kinetics and Safety of Two Different Primes, Adenoviral Vector Vaccine (VRC-HIVADV014-00-VP) and DNA Vaccine (VRC-HIVDNA009-00-VP), Each Followed by Adenoviral Vector Boost in Healthy, HIV-1 Uninfected Adults

NCT00270218•National Institute of Allergy and Infectious Diseases (NIAID)

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

HIV Infections

Interventions

VRC-HIVADV014-00-VP

VRC-HIVDNA009-00-VP

+2 more

Locations

7

United States

Locations (7)

Alabama Vaccine CRS

Birmingham, Alabama, United States

San Francisco Vaccine and Prevention CRS

San Francisco, California, United States

NY Blood Ctr./Union Square CRS

New York, New York, United States

HIV Prevention & Treatment CRS

New York, New York, United States

Univ. of Rochester HVTN CRS

Rochester, New York, United States

Vanderbilt Vaccine CRS

Nashville, Tennessee, United States

Key Dates

Start Date

February 1, 2006

Completion Date

August 1, 2007

Last Updated

October 14, 2021

Related Studies

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047

HIVHIV Infections

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805

WiseApp for Spanish Speakers Living With HIV

NCT05398185

HIV InfectionsAcquired Immune Deficiency Syndrome+1 more

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

NCT07428330

Cervix CancerHIV Infections+1 more

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

NCT07225530

HIV InfectionsHPV Infection+1 more

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

NCT07429864

HBVHBV Coinfection+7 more

View all related studies

Sponsors

Lead Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 14, 2021Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions